RedHill Biopharma RDHL
NASDAQ RDHL
$0.69 +0.04 (+5.31%)
As of: Sep 9, 2026 · 3:59 PM EDT

RedHill Biopharma (RDHL) Gross Margin Growth (3y) (2017 - 2023)

Analysis

RedHill Biopharma (RDHL) Gross Margin Growth (3y) (2017 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 567.00
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -228.00
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -1,218.00
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 528.00
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 313.00
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 32,526.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -137.00
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 91.00
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 42.00
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 2,301.00
Mar 31, 2023 11,762.00
Dec 31, 2022 -1,762.00
Sep 30, 2022 -895.00
Jun 30, 2022 -2,184.00
Mar 31, 2022 -2,402.00
Dec 31, 2021 -4,463.00
Sep 30, 2021 -1,560.00
Jun 30, 2021 -1,840.00
Mar 31, 2021 -1,180.00
Dec 31, 2020 -371.00
Sep 30, 2020 1,203.00
Jun 30, 2020 -1,157.00
Jun 30, 2019 -2,719.00
Dec 31, 2017 -4,593.00
Sep 30, 2017 -6,139.00
Jun 30, 2017 -5,631.00